Bluelinea launches a capital increase with the support of the APICIL Group

On June 25, 2025, Bluelinea announced a €3 million capital increase, fully supported by its majority shareholder, the APICIL Group. This transaction includes a preferential subscription right for existing shareholders, at a price of €0.50 per new share. It involves the issuance of 6,140,337 new shares, with a parity of 1 for 2.

The initiative aims to strengthen Bluelinea's working capital, particularly for its Serenea® solution, which is experiencing strong growth in "Connected Establishments", representing 45% of consolidated revenue in the first quarter of 2025. The subscription period runs from July 3 to 15, 2025, after the detachment of subscription rights on July 1.

The target net proceeds are €2.94 million, which also includes repaying a €300,000 advance received from the APICIL Group. The latter's commitment to cover the entire transaction, both through debt offsetting and cash contributions, secures the project.